Page last updated: 2024-11-04

ethinamate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ethinamate: short duration hypnotic with fast onset & relatively low toxicity; may cause dependence; minor descriptor (76-85); on-line & Index Medicus search CARBAMATES (76-85) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

ethinamate : A carbamate ester that is the 1-vinylcyclohexyl ester of carbamic acid. A short-acting sedative-hypnotic, it was formerly used to treat insomnia. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID3284
CHEMBL ID1576
CHEBI ID4884
SCHEMBL ID44635
MeSH IDM0262973

Synonyms (80)

Synonym
nsc31618
nsc-30282
nsc-31618
nsc30282
einecs 204-789-4
ethynylcyclohexyl carbamate
brn 1946056
1-ethynylcyclohexylcarbamate
etinamato [inn-spanish]
dea no. 2545
valamid
aethinyl-cyclohexyl-carbamat [german]
1-ethinylcyclohexyl carbonate
carbamate de l'ethinylcyclohexanol [french]
nsc 11538
valaminetta
hsdb 3325
ethinamatum [inn-latin]
etinamate
wln: l6tj aovz a1uu1
usaf el-42
cyclohexanol, carbamate
1-ethynylcyclohexyl carbamate
ethinamat
valmidate
valmid
nsc-11538
valaminetten
carbamic acid, 1-ethynylcyclohexyl ester
nsc11538
valaminettae
volamin
valamin
1-ethynylcyclohexanol carbamate
1-ethinylcyclohexyl carbamate
cyclohexanol, 1-ethynyl-, carbamate
nsc-524623
nsc524623
126-52-3
C07832
ethinamate
DB01031
ethinamate (jan/inn)
valmid (tn)
D00703
ethinamatum
CHEBI:4884 ,
aethinyl-cyclohexyl-carbamat
etinamato
CHEMBL1576
(1-ethynylcyclohexyl) carbamate
ethinamate [usp:inn:ban:jan]
ian371pp48 ,
carbamate de l'ethinylcyclohexanol
cyclohexanol, 1-ethynyl-, 1-carbamate
unii-ian371pp48
ethinimate
ethinamate [mi]
ethinamate [orange book]
ethinamate [hsdb]
ethinamate [who-dd]
ethinamate [vandf]
ethinamate [mart.]
ethinamate [inn]
ethinamate [jan]
gtpl7325
[(1-ethynylcyclohexyl)oxy]methanimidic acid
SCHEMBL44635
GXRZIMHKGDIBEW-UHFFFAOYSA-N
DTXSID7023013 ,
ethinamate, analytical standard
HY-101584
CS-6642
carbamic acid 1-ethynylcyclohexyl ester
Q410225
ethinamate (mart.)
ethinamate (usp:inn:ban:jan)
dtxcid803013
ethinamatum (inn-latin)
etinamato (inn-spanish)

Research Excerpts

Dosage Studied

A titrimetric method is described for the determination of three acetylenic hypnotics, namely ethchlorvynol, ethinamate, and methylpentynol carbamate.

ExcerptRelevanceReference
"A titrimetric method is described for the determination of three acetylenic hypnotics, namely ethchlorvynol, ethinamate, and methylpentynol carbamate, in bulk and in dosage forms."( Titrimetric determination of acetylenic hyponotics using organic brominating agents.
Belal, F; el-Brashy, A; Rizk, M; Walash, MI, 1988
)
0.49
"Titrimetric and spectrophotometric titration methods are described for the quantitative determination of acetylenic hypnotics ethchlorvynol, ethinamate, and meparfynol carbamate as pure substances and in dosage forms."( Titrimetric and spectrophotometric determination of acetylenic hypnotics, using brominating agents.
el-Brashy, A; Rizk, MS; Walash, MI,
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
sedativeA central nervous system depressant used to induce drowsiness or sleep or to reduce psychological excitement or anxiety.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
carbamate esterAny ester of carbamic acid or its N-substituted derivatives.
terminal acetylenic compoundAn acetylenic compound which a carbon of the C#C moiety is attached to a hydrogen atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID409954Inhibition of mouse brain MAOA2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
AID409956Inhibition of mouse brain MAOB2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (27)

TimeframeStudies, This Drug (%)All Drugs %
pre-199026 (96.30)18.7374
1990's0 (0.00)18.2507
2000's1 (3.70)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 40.54

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index40.54 (24.57)
Research Supply Index3.37 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index59.54 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (40.54)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.57%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other27 (96.43%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]